Lead sponsor

Radboud University Medical Center

16 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

16

Trials led

1

Active

2,056

Total enrollment

15

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 1
1
Phase 1/2
3
Phase 2
2
Phase 2/3
1
Not applicable
9

Trials by status

Not yet recruiting
1
Completed
5
Terminated
1
Unknown
9

Trials led

TIRZ-DOSE-NLBMI ≥30not applicableNot yet recruiting1,700
GLP-1-AHHPh 1/2Completed56
ELEGANTBMI ≥25not applicableUnknown50
GLP-1-CHIAge ≤16not applicableUnknown40
Ver-A-imagePh 2Unknown30
GLP1R-T2Dnot applicableUnknown28
GLP-1-CPOPnot applicableCompleted20
iPAVEnot applicableCompleted20
BetaFITBMI 18-30Ph 2Unknown20
GLP1-ex-vivonot applicableTerminated12
GLP1-EX-GELOBMI ≥30Ph 1/2Completed12
ENTRAPnot applicableUnknown10